# EDGAR Filing Document

**Accession Number:** 0001074871
**File Stem:** 0001019056-23-000039
**Filing Date:** 2023-1
**Character Count:** 7772
**Document Hash:** 814f02f2c503d85945c0eedc00b26aa8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001019056-23-000039.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0001019056-23-000039

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230117

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Modular Medical, Inc.
- **CENTRAL INDEX KEY:** 0001074871
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 870620495
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41277
- **FILM NUMBER:** 23537756

**BUSINESS ADDRESS:**
- **STREET 1:** 16772 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127
- **BUSINESS PHONE:** 858-800-3500

**MAIL ADDRESS:**
- **STREET 1:** 16772 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BEAR LAKE RECREATION INC
- **DATE OF NAME CHANGE:** 19981208

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

---

| | |
|:---|:---|
| Date of Report (Date of earliest event reported): | **January 17, 2023** |

---

---

| |
|:---|
| **MODULAR MEDICAL, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-41277** | **87-0620495** |
| (State or other jurisdiction<br>of incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification No.) |

---

---

| | |
|:---|:---|
| **16772 W. Bernardo Drive, San Diego, California** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **92127** |
| (Address of principal executive offices) | (Zip Code) |

---

---

| | |
|:---|:---|
| Registrant's telephone number, including area code: | **(858) 800-3500** |

---

<br>   <br> (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Common Stock | MODD | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.** |

---

(a) On January 17, 2023, Modular Medical, Inc. (the "Company") held its annual meeting of shareholders for the fiscal year ended March 31, 2022 (the "Annual Meeting"), and a quorum for the transaction of business was present in person virtually or represented by proxy. The Company's shareholders voted on six proposals, which are described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on December 20, 2022.

(b) Voting results were as follows:

· Proposal
 1 – Election of directors to serve until the next annual meeting of shareholders.

---

| | | | |
|:---|:---|:---|:---|
|  | For | Withheld | Broker Non-Vote |
| Paul DiPerna | 6316874 | 24074 | 1473940 |
| William Febbo | 6223061 | 118517 | 1473940 |
| Steven Felsher | 6085541 | 256037 | 1473940 |
| Morgan Frank | 6316874 | 24074 | 1473940 |
| Philip Sheibley | 6337468 | 4110 | 1473940 |
| Carmen Volkart | 6232034 | 109544 | 1473940 |
| Ellen O'Connor Vos | 6060874 | 280704 | 1473940 |

---

All of the foregoing candidates were elected to serve as directors until the next annual meeting of shareholders and until the election and qualification of her or his successor or earlier resignation or removal.

· Proposal
 2 – Amendment of the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder
 by 2,000,000 shares.

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstain | Broker Non-Vote |
| 6135990 | 156846 | 48742 | 1437940 |

---

· Proposal
 3 – Approval, on an advisory basis, of the executive compensation of the Company's named executive officers.

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstain | Broker Non-Vote |
| 6263648 | 28468 | 49462 | 1473940 |

---

· Proposal
 4 – Recommendation, on a non-binding advisory basis, on the frequency of future advisory votes on the compensation of the Company's
 named executive officers.

<u>One Year</u> <u>Two Years</u> <u>Three Years</u> <u>Abstain</u> <br> 671,818 4,799 5,664,961 —

· Proposal
 5 – Ratification of the audit committee's appointment of Farber Hass Hurley LLP as the Company's independent registered
 public accounting firm for the fiscal year ending March 31, 2023.

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstain | Broker Non-Vote |
| 7814759 | 39 | 720 |  |

---

· Proposal
 6 – Approval of one or more adjournments of the Annual Meeting.

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstain | Broker Non-Vote |
| 7659802 | 155549 | 167 |  |

---

On the basis of the voting results, the proposals to (i) amend the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares; and (ii) ratify the audit committee's appointment of Farber Hass Hurley LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2023 were adopted.

On the basis of the voting results, shareholders also voted a sufficient number of non-binding advisory votes to recommend that the frequency of the advisory vote on the compensation of the Company's named executive officers be held every 3 years and approve, on an advisory basis, the compensation of the Company's named executive officers.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

(d) Exhibits:

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **MODULAR MEDICAL, INC.** | **MODULAR MEDICAL, INC.** |
| Date: January 19, 2023 | By: | /s/ James E. Besser |
|  |  | James E. Besser |
|  |  | Chief Executive Officer |

---